---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-152914"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2021-12-23T23:59:59+00:00"
generated_at: "2026-06-27T22:39:45.442158+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Stockholders re-elect all five directors and approve 1.52M share increase to incentive plan at 2021 annual meeting

## Summary
- All five director nominees (Shulman, Silverman, Bernstein, Bradley, Walker) re-elected with >99% votes cast in favor.
- Second Amendment to 2020 Omnibus Incentive Plan approved (5.86M for, 85K against), increasing shares reserved to 2.6M.
- EisnerAmper LLP ratified as independent auditor for FY2021 with 9.18M votes for, 36.8K against.
- Advisory say-on-pay passed with 5.89M for (98.9% of votes cast); shareholders chose 1-year frequency for future votes.
- Voter turnout: 9.23M of total voting power; broker non-votes of ~3.26M on most proposals.

## SEC filing metadata
- accession: 0001104659-21-152914
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2021-12-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465921152914/0001104659-21-152914-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465921152914/tm2136177d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-152914
- JSON: https://secwatch.observer/filing/0001104659-21-152914.json
- Plain text: https://secwatch.observer/filing/0001104659-21-152914.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.